Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | GATAD2A |
| Upstream (Parents) |
|---|
| (<<) NR2F1 → GATAD2A |
| (<<) JUND → GATAD2A |
| (<<) TCF4 → GATAD2A |
| (<<) RORA → GATAD2A |
| (<<) FOXO3 → GATAD2A |
| (<<) MEF2C → GATAD2A |
| (<<) STAT3 → GATAD2A |
| (<<) NFKB2 → GATAD2A |
| (<<) ERF → GATAD2A |
| (<<) NFATC3 → GATAD2A |
| (<<) JUN → GATAD2A |
| (<<) ETS2 → GATAD2A |
| (<<) SMAD5 → GATAD2A |
| (<<) SPI1 → GATAD2A |
| (<<) RELA → GATAD2A |
| (<<) SALL1 → GATAD2A |
| (<<) GABPA → GATAD2A |
| Downstream (Children) |
|---|
| GATAD2A → WNT5A (>>) |
| GATAD2A → DLX1 (>>) |
| GATAD2A → TFDP2 (>>) |
| GATAD2A → SMAD6 (>>) |
| GATAD2A → NFATC4 (>>) |
| GATAD2A → ZNF92 (>>) |
